 | • レポートコード：MRC2203A116 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の心臓血管・軟組織修復パッチ市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、原材料別（生体材料・組織エンジニアリング材料、ePTFE、その他）分析、用途別（心臓修復、軟組織修復、血管修復・再建、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の心臓血管・軟組織修復パッチ市場規模：原材料別（生体材料・組織エンジニアリング材料、ePTFE、その他） ・世界の心臓血管・軟組織修復パッチム市場規模：用途別（心臓修復、軟組織修復、血管修復・再建、その他） ・世界の心臓血管・軟組織修復パッチ市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Admedus、LeMaitre Vascular Inc.、Baxter、…） ・市場機会・将来傾向 |
The Cardiovascular and Soft Tissue Repair Patches Market is expected to register a CAGR of 8% during the forecast period. This is attributing to technological advancements, increasing prevalence of congenital heart diseases, increasing R&D expenditure. In addition, the rising prevalence of atrial and ventricular septal in hearth birth defects and growing inclination towards minimally invasive procedures also result in high adoption of the patches and trigger the growth of the market. Moreover, increase in the prevalence of congenital diaphragmatic hernias, an inguinal hernia is also promoting the growth pf the market as these patches are used in the treatment of these disorders by tissue repairing procedures. As per the National Institute of Diabetes and Digestive and Kidney Diseases, an inguinal hernia is a common disorder around the globe and representing at least 27 percent of men and 3 percent of women at some point in their lives. Furthermore, increasing collaboration between manufacturers and research organizations, government initiatives associated with cardiac treatments, and the development of novel technologies are few more factors driving the growth of cardiovascular and soft tissue repair patches market.
Key Market Trends
Soft Tissue Repair in Cardiac and Soft Tissue Repair Patches is Estimated to Witness a Healthy Growth in Future.
Soft tissue repair is estimated to witness healthy growth in the future attributed to the increasing prevalence of various types of hernias. A hernia is a disorder where an organ or any fatty tissue bulges out though an abnormal opening. Soft tissue repair patches help in diagnosing the hernia disorder. As per the report published by Santhini Elango in 2017, the incidence of hernia is rising at an alarming rate among the population over 50 years old in India and around 2% of the population are affected by hernia making it highly prevalent across the globe and drive the segment growth.
In addition, As per SWEDCON, the number of children with congenital heart diseases is increasing from the past year and thus leading to the adoption of these cardiovascular soft tissue repair patches for diagnosing and drive the overall market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Cardiovascular and Soft Tissue Repair Patches Market due to the rising prevalence of cardiac diseases, the presence of a large number of pharmaceutical companies, growing research and development expenditure, and increasing incidences of hernia disorders.
As per the report published in Annals of Laparoscopic and Endoscopic Surgery 2019, annually 350,000 abdominal wall hernia repairs are being performed in the United States. The United States owns the largest share of Cardiovascular and Soft Tissue Repair Patches Market in the North America region Furthermore, the presence of developed infrastructure and growing awareness regarding the availability of novel products are also expected to fuel the Cardiovascular and Soft Tissue Repair Patches Market in this region.
Competitive Landscape
The Cardiovascular and Soft Tissue Repair Patches Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Admedus, LeMaitre Vascular Inc., Baxter, Cryolife, Inc., CorMatrix, Inc, Abbott (St Jude Medical), B. Braun Melsungen AG, Terumo Medical Corporation, Integra LifeSciences Corporation, and Glycar SA Pty Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements
4.2.2 Increasing Prevalence of Congenital Heart Diseases
4.2.3 Increasing R&D Expenditure
4.3 Market Restraints
4.3.1 Regulatory Framework
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Raw Material
5.1.1 Biomaterial and Tissue Engineered Material
5.1.2 ePTFE
5.1.3 Others
5.2 By Application
5.2.1 Cardiac Repair
5.2.2 Soft Tissue Repair
5.2.3 Vascular Repair & Reconstruction
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Admedus
6.1.2 LeMaitre Vascular Inc.
6.1.3 Baxter
6.1.4 Cryolife, Inc.
6.1.5 CorMatrix, Inc
6.1.6 Abbott (St Jude Medical)
6.1.7 B. Braun Melsungen AG
6.1.8 Terumo Medical Corporation
6.1.9 Integra LifeSciences Corporation
6.1.10 Glycar SA Pty Ltd.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS